Results 121 to 130 of about 282,933 (302)
The Shewanella oneidensis Fic enzyme SoFic targets the switch‐I region of EF‐Tu for AMPylation
Fic enzymes mediate diverse post‐translational modifications across all domains of life, including AMPylation. Prokaryotic EF‐Tu can be AMPylated and deAMPylated by the conserved Fic enzyme SoFic. Structural and biochemical approaches were used to characterize the effect of AMPylation on EF‐Tu, SoFic's enzymatic activities, and the enzyme‐target ...
Svenja Runge +6 more
wiley +1 more source
Purpose Norwegian Pakistanis use traditional and complementary medicines (T&CM) to promote well-being and treat illnesses. Effective communication between T&CM users and healthcare providers (HCPs) about these practices is essential for patient safety ...
Saliha Khalid +4 more
doaj +1 more source
Defining research priorities in complementary medicine in oncology
Objectives: The high usage of complementary and alternative medicines (CAM) by cancer patients is increasing, despite limited research available to support their use.
Bensoussan, Alan (R7273) +2 more
core +1 more source
Prospecting the protein design landscape
This review outlines the current state of various protein design approaches. We discuss the current possibilities enabled by recently released tools, highlight future avenues to pursue in protein design, and underscore the crucial role of key databases and resources for successful protein design workflows.
Jakob R. Riccabona +4 more
wiley +1 more source
The role of miR‐335‐5p in the redifferentiation of BRAF p.V600E thyroid cancers
The BRAF p.V600E mutation promotes thyroid cancer dedifferentiation and radioiodine resistance. Using a network approach, we identified miR‐335‐5p as a key regulator of BRAF‐mutated thyroid tumors. Restoring miR‐335‐5p increased thyroid‐specific gene expression and iodine uptake in cells and organoids.
Valeria Pecce +11 more
wiley +1 more source
The objective of the research was to map the discourse about herbal medicine in Australia’s primary medical journal, the Medical Journal of Australia, over 4 decades. Manifest content analysis of 148 articles about herbal or complementary and alternative
Lewis, Monique, Lewis, M, Monique Lewis
core +1 more source
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla +9 more
wiley +1 more source
Background Each year, over 20,000 men are diagnosed with cancer in Norway, and approximately 150,000 men who have previously been diagnosed with cancer are currently alive. Many of these cancer survivors encounter a range of challenges, including fatigue,
Agnete E. Kristoffersen +5 more
doaj +1 more source
Background: Pulse diagnosis in Thai Traditional Medicine (TTM) evaluates the balance of the Tri-Dhātu—Vata, Pitta, and Semha—and their interaction with innate body elements (Dhātu Chao Ruean; DCR).
Athippat Tantiwongsekunakorn +4 more
doaj +1 more source
Regulation of complementary medicine practitioners in Australia : Chinese medicine as a case example
Complementary and alternative medicine (CAM) forms a significant part of the health economy. CAM practices are under increased scrutiny from consumers, clinicians, scientists and regulators.
Bensoussan, Alan, Carlton, Anne-Louise
core

